Phase II trial shows improved PFS when relacorilant is added to nab-paclitaxel in ovarian cancer May 7, 2021
Erasca opens enrollment in phase Ib/II study of ERAS-007 in advanced or metastatic solid tumors May 7, 2021
RSS